Status:
RECRUITING
A Study of Freeze-dried Human Protein C Concentrate (TAK-662) in Participants With Congenital Protein C Deficiency
Lead Sponsor:
Takeda
Conditions:
Protein C Deficiency
Eligibility:
All Genders
Brief Summary
This study is conducted in Japan of Freeze-dried Human Protein C Concentrate (TAK-662) used to treat participants with congenital protein C deficiency. The main aim of the study is to evaluate for ad...
Eligibility Criteria
Inclusion
- \- All participants with congenital protein C deficiency who are administered with Freeze-dried Human Protein C Concentrate (TAK-662).
Exclusion
- \- None
Key Trial Info
Start Date :
September 6 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2030
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT06590974
Start Date
September 6 2024
End Date
June 30 2030
Last Update
August 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Takeda selected site
Tokyo, Tokyo, Japan